Destroy to create: E3 ubiquitin ligases in neurogenesis by Stegmüller, Judith & Bonni, Azad
Destroy to create: E3 ubiquitin ligases in neurogenesis
Judith Stegmüller
1 and Azad Bonni
2 *
Addresses:
1Max-Planck-Institute of Experimental Medicine, Hermann Rein Strasse 3, 37075 Göttingen, Germany;
2Department of Pathology,
Harvard Medical School, 77 Ave Louis Pasteur, Boston, MA 02115, USA
*Corresponding author: Judith Stegmüller (stegmueller@em.mpg.de)
F1000 Biology Reports 2010, 2:38 (doi:10.3410/B2-38)
The electronic version of this article is the complete one and can be found at: http://f1000.com/reports/biology/content/2/38
Abstract
The ubiquitin proteasome system (UPS) has drawn tremendous attention in the field of neuroscience.
In recent years, we have gained insights into UPS-dependent mechanisms in brain development and
disease. Several interesting studies over the past two years have highlighted the role of distinct
E3 ubiquitin ligases in neurogenesis. Here, we will review the major findings in these studies and
discuss their implications.
Introduction and context
The major function of the ubiquitin proteasome system
(UPS) is to provide the regulated degradation of
proteins [1]. The UPS consists of sets of enzymes that
mark a protein destined for degradation with a
polyubiquitin chain. In an enzymatic cascade, ubiqui-
tin, which is a small 8.5-kDa protein, is first covalently
linked to the E1 ubiquitin-activating enzyme in an
energy-dependent manner. Subsequently, ubiquitin is
transferred onto the E2 ubiquitin-conjugating enzyme.
Finally, the E3 ubiquitin ligase recruits both the
E2 ubiquitin-conjugating enzyme and substrate, thereby
facilitating the transfer of ubiquitin to the substrate. The
processivity of the ubiquitination reaction leads to the
formation of a polyubiquitin chain. Polyubiquitinated
substrates are recognized by the proteasome, leading
to the degradation of the substrate. While there are
two characterized E1 enzymes and approximately
35 E2 enzymes, E3 ligases are quite numerous, with
more than 600 enzymes [2]. Although E3 ligases confer
substrate specificity, individual E3 ligases can recruit
more than one substrate. Conversely, substrates may be
targeted by more than one E3 ligase [3,4]. Among
E3 ligases, RING (really interesting new gene)-type
ligases represent the largest group and are composed of
a single subunit or multisubunit complexes [2]. The
RING-type E3 ligases operate as scaffolds to recruit both
the E2 and the substrate to facilitate ubiquitination.
In contrast, members of the smaller family of HECT
(homologues to E6AP C-terminus) ligases harbor
enzymatic activity, which mediates the transfer of
ubiquitin to the target [5]. Besides the control of
protein abundance, ubiquitination regulates diverse
aspects of cellular signaling and physiology [6,7].
Over the past few years, a number of E3 ubiquitin ligases
have been reported to play critical roles in diverse aspects
of neuronal development, including axon, dendrite, and
synapse morphogenesis (for reviews, see [8-10]). In this
review, we will focus on recent studies implicating
E3 ubiquitin ligases in the regulation of neurogenesis
(Figure 1).
Major recent advances
E3 ubiquitin ligase pathways regulating neurogenesis
Neurogenesis requires the precise and sophisticated
orchestration of many signaling events [11]. One way
of determining the cell fate is to epigenetically program
the genome to restrict the expression of genes that favor
one cell fate over another. In this regard, a prominent
factor is the repressor element 1 (RE-1)-silencing
transcription factor (REST), also known as NRSF
(neuron-restrictive silencing factor), which is a DNA-
binding protein that recognizes a conserved motif
present in many neuronal genes [12,13]. To ensure
permanent gene silencing, REST associates with the
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HDACs (histone deacetylases) to target genes [12]. The
REST-dependent silencing mechanism is found in all
non-neuronal cells, including those within the nervous
system,raising the question of how precursor cells escape
this silencing program to acquire a neuronal cell fate.
A recent study by Westbrook and colleagues [14] provides
insight into this problem. The authors found that REST is
polyubiquitinated and hence subjected to proteasomal
degradation in embryonic stem (ES) cells. The authors
then identified SCF
bTRCP as the E3 ubiquitin ligase that
targets REST for degradation. SCF
bTRCP is an SCF complex
consisting of the adaptor proteins Skp1 and Cullin1, the
RING component Roc1, and the F-box protein bTRCP
(beta-transducin repeat containing protein), which con-
fers substrate specificity [15]. The recruitment of most
F-box proteins, including bTRCP, requires a phosphory-
lated recognition motif within the substrate [15]. Corre-
spondingly, REST is recruited to SCF
bTRCP in a
phosphodegron-dependent manner. To test the effect of
the REST/SCF
bTRCP interaction on neuronal gene expres-
sion,EScellsharboringaSox1reportergeneasamarkerof
early-stage neurogenesis were transfected with REST,
SCF
bTRCP, or control short interfering RNAs (siRNAs).
Knockdown of bTRCP led to significantly fewer Sox1-
positive cells as compared with control cells. In contrast,
knockdown of REST strongly induced Sox1 expression.
A comparably strong induction of Sox1 expression was
obtained by simultaneous knockdown of REST and
bTRCP. In other experiments, ES cells containing the
Sox1 reporter were transfected with wild-type or degron-
mutant REST and placed in differentiation media. Expres-
sionofmutantREST,butnotwild-typeREST,dramatically
reduced Sox1 expression. Taken together, these findings
identify REST as a novel target of the E3 ubiquitin ligase
SCF
bTRCP and support the conclusion that SCF
bTRCP acts
upstream of REST to control neurogenesis. While REST
imposes a non-neuronal cell fate at an epigenetic level,
controlled clearance of REST favors a neuronal cell fate by
derepressionandsubsequentinductionofneuronalgenes.
The HECT domain E3 ubiquitin ligase Huwe1 employs
a strategy similar to that of SCF
bTRCP to promote
neurogenesis. The transcription factor N-Myc maintains
the proliferation of precursor cells in the nervous system
[16,17]. Previous studies have revealed that N-Myc
undergoes proteasome-dependent degradation [18,19].
In an effort to determine how N-Myc is regulated,
Lasorella and colleagues [20] used an unbiased bio-
chemical approach to identify proteins that form a
physical complex with N-Myc. The authors identified the
E3 ubiquitin ligase Huwe1 as a new N-Myc-interacting
protein. Huwe1 triggered the polyubiquitination and
subsequent degradation of N-Myc [20]. To determine the
functional consequence of Huwe1-mediated degrada-
tion of N-Myc in ES cells, wild-type and Huwe1 knockout
ES cells were placed in differentiating conditions. While
differentiated wild-type ES cells expressed neuronal
genes, including neurogenin, n-cadherin,a n dMAP2,
Huwe1 knockout ES cells failed to express these markers.
Furthermore, knockout of Huwe1 in ES cells led to the
accumulation of N-Myc protein. In other experiments,
ex utero electroporation analyses of the cerebral cortex
revealed that knockdown of N-Myc significantly
decreased the number of proliferating cells and increased
the number of neurons, suggesting that N-Myc knock-
down leads to cell cycle exit of precursor cells. In contrast,
knockdown of Huwe1 restored the proliferative nature of
the cells and prevented differentiation along the neuro-
nal lineage. In epistasis analyses, knockdown of N-Myc
suppressed the Huwe1 knockdown-induced phenotype
of increased cell proliferation and impaired differentia-
tion, supporting the conclusion that N-Myc acts down-
stream of Huwe1 in precursor cells in the cerebral cortex.
In a follow-up study, Zhao and colleagues [21] reported
conditional knockout of Huwe1 in the cerebral cortex of
mice. The authors also provided evidence suggesting that
the gene encoding the Notch ligand Delta-like 3 (Dll3)
may act as a target of N-Myc. Accordingly, Dll3 levels are
elevated in Huwe1-null brains as compared with wild-
type brain. By silencing N-Myc and Dll3 in Huwe1
knockout animals, the loss-of-Huwe1 phenotype of
hyperproliferation and defective differentiation
was reversed. Huwe1 ensures a low level of N-Myc at
Figure 1. E3 ubiquitin ligases in neurogenesis
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The E3 ubiquitin ligases SCF-bTRCP, Huwe-1, TRIM32, or TRIM11 promote
neurogenesis by targeting their respective substrates REST, N-Myc, c-Myc,
or PAX6 for degradation by the proteasome. bTRCP, beta-transducin
repeat containing protein; REST, repressor element 1-silencing transcription
factor; SCF; Skp, Cullin, F-box containing; TRIM, tripartite motif.
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precursors are scheduled to differentiate. Destruction of
N-Myc results in the suppression of the dll3 gene. The
authors reasoned that inactivation of the Dll3-notch
pathway is critical for neural precursors to acquire a
neuronal cell fate and that Huwe1 acts in a critical
developmental window to target N-Myc for degradation
and to induce neurogenesis.
Prior to acquiring a neuronal cell fate, the multipotential
neural precursor cell undergoes asymmetric cell division,
giving rise to a multipotential precursor cell and a
restricted neuronal progenitor cell [22]. The latter
inherits cell fate-determining proteins that initiate the
production of neurons [22]. An asymmetrically distrib-
uted determinant is the ubiquitin ligase TRIM32
(tripartite motif-containing 32) [23,24]. TRIM32 is a
member of the tripartite interaction motif family of
single-subunit E3 ligases. These proteins typically harbor
a RING domain, a B-box domain (BB), and a coiled-coil
domain(CC).Thefamilyconsistsofatleast65members,
which are implicated in diverse cellular functions and
pathological conditions [25]. The Drosophila orthologue
of TRIM32, Brat, has been identified as a determinant of
cell fate. Once inherited by the daughter cell, Brat triggers
neuronal differentiation of Drosophila neuroblasts [23].
In addition, Drosophila Brat has been identified as an
interaction partner of the RNAase Argonaute 1 (Ago1)
[26]. Also, the transcription factor dMyc was found to be
regulated post-transcriptionally downstream of Brat. The
exact regulatory mechanism, however, remained unex-
plored until recently [23].
Schwamborn and colleagues [24] investigated TRIM32
function in the mammalian cerebral cortex. TRIM32
displayed an asymmetrical distribution in dividing
precursor cells and was enriched in one of the two
daughter cells [24]. In overexpression analyses of
precursor cells, TRIM32 potently induced neuronal cell
fate as monitored by neuron-specific class III b-tubulin
expression. In addition to the conserved proneuronal
function of TRIM32, the binding to Ago1 is conserved
across species. Interestingly, the TRIM32/Ago1 complex
was found to bind to and activate the microRNA
(miRNA) let-7a, which promoted the expression of
class III b-tubulin in precursor cells. This proneural
function of TRIM32, however, is independent of its
ligase activity. To establish a functional relationship of
TRIM32 and c-Myc based on the authors’ previous
findings [23], TRIM32 was subjected to immunopreci-
pitation analyses and found to interact with c-Myc.
In addition, the RING domain of TRIM32 was required
for the polyubiquitination and consequent degradation
of c-Myc. Importantly, the degradation of c-Myc triggered
cell cycle exit of mitotic cells, and expression of RING-
defective TRIM32 or TRIM32 together with c-Myc failed
to induce neuronal differentiation in the cerebral cortex.
Hence, the authors proposed a model in which TRIM32
triggers at least two events that promote neurogenesis:
TRIM32 activates miRNAs and targets c-Myc for protea-
somal degradation. Thus, the degradation of Myc family
members appears to be a recurring concept in cells that
differentiate along the neuronal lineage.
TRIM11 represents another member of the TRIM family
that has been implicated in the regulation of neurogenesis.
TuocandStoykova[27]recentlyreportedthatTRIM11may
regulate the abundance of the transcription factor Pax6 in
neural precursor cells. TRIM11 binds to and polyubiqui-
tinates Pax6, thus triggering its degradation by the
proteasome. Intriguingly, TRIM11 clears the cell of
insoluble Pax6. Overexpression of TRIM11 in cortical
precursor cells inhibits neuronal differentiation. Using
siRNAs to silence TRIM11, the authors showed that
TRIM11 knockdown led to the accumulation of Pax6 in
corticalprecursorcells,leadingtoapoptosis.WhileTRIM11
gain-of-function impaired neurogenesis, TRIM loss-
of-function induced apoptosis. Interestingly, TRIM11 itself
is a Pax6-controlled gene, providing an elegant feedback
mechanism of substrate and E3 ligase [27]. In summary,
Tuoc and Stoykova [27] present a model in which TRIM11
regulates Pax6 levels to ensure the correct gene dosage
of Pax6-controlled genes to promote neurogenesis.
Future directions
The featured studies in this review explore the role of the
UPS in neurogenesis. Future studies in this area should
provide further insights into the role of ubiquitin ligases
in neurogenesis. The physiologic role of each of the
E3 ubiquitin ligases in the development and function of
the nervous system remains to be elucidated. In addition,
how each of the E3 ubiquitin ligases, SCF
bTRCP, Huwe1,
TRIM32, and TRIM11, is regulated in neural precursor
cells will be a fruitful avenue for future research. Finally,
it will be interesting to determine whether and how these
distinct ubiquitin signaling pathways might interact with
each other in neural stem cells and in the course of
neuronal differentiation.
In view of the large number of E3 ubiquitin ligases, we
are just beginning to gain an understanding of the role of
these enzymes in the early events of neuronal develop-
ment. Recent studies have implicated the major cell cycle
ubiquitin ligases Cdh1-anaphase-promoting complex
(Cdh1-APC) and Cdc20-APC in distinct aspects of
neuronal development [9,10,28]. In particular, Cdh1-
APC has been implicated in the control of axon growth
and patterning, whereas Cdc20-APC has been implicated
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tic differentiation in the mammalian brain [29-33].
Cdh1-APC has also been implicated in the control of
synapse development in invertebrates [34,35]. Recent
studies have broadened the roles of Cdh1-APC beyond
development to the control of glycolysis and synapse
function in the mature nervous system [36-38]. Interest-
ingly, the roles of Cdh1-APC and Cdc20-APC in
neurogenesis in the mammalian brain have yet to be
elucidated. Since Cdh1-APC and Cdc20-APC are critical
regulators of cell cycle progression, these ligases are
anticipated to have important functions in the early
events of neuronal development.
Beyond the APC, it will be interesting to explore the role
of additional E3 ubiquitin ligases in neurogenesis.
Screens might be a useful approach to identify novel
E3 ligases that regulate neurogenesis. Since deregulation
of mechanisms of neurogenesis is thought to play a
critical role in disease pathogenesis [39], the identifica-
tion of ubiquitin ligase pathways that control neurogen-
esis will advance our understanding of brain
development and diseases. These studies also raise the
prospect that therapies that target E3 ligases in order to
stimulate neurogenesis in the adult brain may be
developed. It will be an exciting and worthwhile
endeavor to shed light on the complexity of E3 ubiquitin
ligase function in neurogenesis.
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